Therapeutic Ultrasound in the Treatment of Migraine

Bursa Yüksek İhtisas Education and Research Hospital

Status: Completed

Conditions: Migraine; Ultrasound

Treatments: Device: therapeutic ultrasound; Device: placebo ultrasound

Study type: Interventional

Funder types: Other

Identifiers

NCT03459495

2011-KAEK-2018-1/25

Details and patient eligibility

About

Headache affects the daily quality of life of patients. It has been reported that headaches may be associated with neck muscles, neck movements and trigger points in the neck Drug and non-drug treatments can be used today in the treatment of headaches. Various physical therapies are applied to cranial and cervical regions in non-drug therapies. Therapeutic ultrasound, Transcutaneous Electrical Nerve Stimulation (TENS), Hotpack and manipulation are some of them.This is a randomised placebo- controlled trial to determine the efficacy of the therapeutic ultrasound in the treatment of migraine.

Full description

Evidence from controlled studies suggests that non-invasive physical therapies may help prevent headaches. Therapeutic ultrasound studies have generally been used in combination with other physical therapies.

Therapeutic ultrasound is known to act in two different ways, thermal and non-thermal. With thermal effect, it is possible to reduce pain and joint joints and increase local blood flow, while stimulating tissue regeneration, soft tissue repair, blood flow regulation in chronic ischemic tissues and protein synthesis with nonthermal effect. In addition, its effect on inflammation accelerated repair by affecting cell activities, altering platelet membrane permeability, leading to the release of serotonin and accelerating wound healing.

The aim of this study is to determine whether therapeutic ultrasound is superior to placebo ultrasound in the treatment of migraine.

Enrollment: 58 patients

Sex: All

Ages: 20 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients between 20-65 years
• Patients diagnosed with migraine according to the International Headache Society (IHS) criteria

Exclusion criteria

• Patients with bleeding disorders,
• Patients with mental disorders,
• Patients with malignancy,
• Patients with uncontrolled hypertension,
• Patients with uncontrolled diabetes mellitus,
• Patients with infection,
• Patients who underwent surgery in the posterior cranial region and cervical vertebra.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

58 participants in 2 patient groups, including a placebo group

Group A

Active Comparator group

Description:

Group A: ultrasound group

Treatment:

Device: therapeutic ultrasound

Group P

Placebo Comparator group

Description:

Group P: placebo ultrasound group

Treatment:

Device: placebo ultrasound